Ligand · I4I
I4I · 3-hydroxy-N-[(2R,5R,6S,9S,10S,11R)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-2-(propan-2-yl)-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl]pyridine-2-carboxamide
I4I, 3-hydroxy-N-[(2R,5R,6S,9S,10S,11R)-10-hydroxy-5,11-dimethyl-3,7,12-trioxo-2-(propan-2-yl)-9-(pyridin-3-ylmethyl)-1,4-dioxa-8-azacyclododecan-6-yl]pyridine-2-carboxamide (C26 H32 N4 O8, 528.5 g/mol), in the MolNFT structures on…
- Component
- I4I
- Formula
- C26 H32 N4 O8
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
I4I in 2 structures; the first of them:
- 4BGI · Crystal structure of InhA(S94A) mutant in complex with OH-141 · I4I A1270 · binds ILE21, ALA94, ILE95, GLY96, MET103, MET147, ASP148, PHE149 and 10 more
- 4BGI · Crystal structure of INHA(S94A) mutant in complex with oh-141 · I4I A1270 · binds ILE21, ALA94, ILE95, GLY96, MET103, MET147, ASP148, PHE149 and 10 more
Residues it binds most
MET 6, ILE 6, ALA 6, GLY 6, ASP 6, LEU 6, LYS 6, PHE 6, PRO 6, TYR 6 (residue and the binding sites it lines).
Found with
- NAD · Nicotinamide-adenine-dinucleotide
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.